TissueNetix is dedicated to developing novel assays that make use of human cells to help eliminate toxic compounds during the drug discovery process. We are developing a novel microplate format of beating, conducting human cardiomyocytes for the most accurate and efficient drug cardiotoxicity screening. TissueNetix applies cell engineering to address unmet needs in the drug discovery process, and plans to develop a portfolio of novel tools for preclinical and diagnostic applications.